nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab
|
Anwar, Hoda |
|
2017 |
45 |
3 |
p. 376-383 |
artikel |
2 |
Clinical utility of FDG PET/CT in acute complicated pyelonephritis—results from an observational study
|
Wan, Chih-Hsing |
|
2017 |
45 |
3 |
p. 462-470 |
artikel |
3 |
Current status of theranostics in prostate cancer
|
Virgolini, Irene |
|
2017 |
45 |
3 |
p. 471-495 |
artikel |
4 |
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma
|
Palard, Xavier |
|
2017 |
45 |
3 |
p. 392-401 |
artikel |
5 |
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems
|
Kaalep, Andres |
|
2017 |
45 |
3 |
p. 412-422 |
artikel |
6 |
FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer
|
Lovinfosse, Pierre |
|
2017 |
45 |
3 |
p. 365-375 |
artikel |
7 |
18F–fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment
|
Sung, Pil Soo |
|
2017 |
45 |
3 |
p. 384-391 |
artikel |
8 |
Founder of EJNM passed away
|
Knapp, Wolfram H. |
|
2017 |
45 |
3 |
p. 518-519 |
artikel |
9 |
Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer’s disease and frontotemporal dementia
|
Jang, Young Kyoung |
|
2017 |
45 |
3 |
p. 432-442 |
artikel |
10 |
Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue
|
Gains, Jennifer E. |
|
2017 |
45 |
3 |
p. 402-411 |
artikel |
11 |
Incidental identification of osteoid osteoma by 68Ga-PSMA PET/CT
|
Castello, Angelo |
|
2017 |
45 |
3 |
p. 509-510 |
artikel |
12 |
Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy
|
Cho, Nariya |
|
2017 |
45 |
3 |
p. 328-339 |
artikel |
13 |
Is the whole larger than the sum of the parts? Integrated PET/MRI as a tool for response prediction
|
Mottaghy, Felix M. |
|
2017 |
45 |
3 |
p. 325-327 |
artikel |
14 |
177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?
|
Rahbar, Kambiz |
|
2017 |
45 |
3 |
p. 513-514 |
artikel |
15 |
Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson’s disease
|
Yoo, Han Soo |
|
2017 |
45 |
3 |
p. 423-431 |
artikel |
16 |
Prognostic value of 18F–choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide
|
Caroli, Paola |
|
2017 |
45 |
3 |
p. 348-354 |
artikel |
17 |
Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)
|
Jambor, Ivan |
|
2017 |
45 |
3 |
p. 355-364 |
artikel |
18 |
Reply to ‘Single high dose versus repeated bone-targeted radionuclide therapy’
|
Denis-Bacelar, Ana M. |
|
2017 |
45 |
3 |
p. 515-517 |
artikel |
19 |
Simultaneous whole-body 18F–PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot study
|
Freitag, Martin T. |
|
2017 |
45 |
3 |
p. 340-347 |
artikel |
20 |
Static and dynamic 18F–FET PET for the characterization of gliomas defined by IDH and 1p/19q status
|
Verger, Antoine |
|
2017 |
45 |
3 |
p. 443-451 |
artikel |
21 |
Striking lack of visualization of striatum on 18F-FDG brain PET in chorea-acanthocytosis
|
López-Mora, Diego Alfonso |
|
2017 |
45 |
3 |
p. 511-512 |
artikel |
22 |
Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review
|
Eyben, Finn Edler von |
|
2017 |
45 |
3 |
p. 496-508 |
artikel |
23 |
Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging
|
Ezawa, Naoki |
|
2017 |
45 |
3 |
p. 452-461 |
artikel |